Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis

Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis

Background. Recently, a growing number of case reports and case series have suggested that the use of recombinant activated factor VII (rFVIIa) may be effective in treatment of patients with non-hemophilic acquired coagulopathy not responding to conventional treatment such as major surgery, major tr...

Full description

Bibliographic Details
Main Authors: Stefanović Branislav, Stefanović Branislava, Mijatović Srđan, Radenković Dejan, Popović Nada, Šijački Ana, Lačković Vesna
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2009-01-01
Series:Vojnosanitetski Pregled
Subjects:
factor VIIa
hemorrhage
retroperitoneal space
pancreatitis
digestive system surgical procedures
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2009/0042-84500911928S.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2009/0042-84500911928S.pdf

Similar Items